JT-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JT-001, covering 2022-03-07 to 2022-03-07. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]